JP2016528176A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528176A5
JP2016528176A5 JP2016517683A JP2016517683A JP2016528176A5 JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5 JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5
Authority
JP
Japan
Prior art keywords
protein
nucleic acid
acid molecule
hbcag
copies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016528176A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2014/051739 external-priority patent/WO2014195713A1/en
Publication of JP2016528176A publication Critical patent/JP2016528176A/ja
Publication of JP2016528176A5 publication Critical patent/JP2016528176A5/ja
Pending legal-status Critical Current

Links

JP2016517683A 2013-06-06 2014-06-05 シングルドメイン抗体ディスプレイ Pending JP2016528176A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361831707P 2013-06-06 2013-06-06
US61/831,707 2013-06-06
PCT/GB2014/051739 WO2014195713A1 (en) 2013-06-06 2014-06-05 Single domain antibody display

Publications (2)

Publication Number Publication Date
JP2016528176A JP2016528176A (ja) 2016-09-15
JP2016528176A5 true JP2016528176A5 (enExample) 2017-07-13

Family

ID=51022893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016517683A Pending JP2016528176A (ja) 2013-06-06 2014-06-05 シングルドメイン抗体ディスプレイ

Country Status (6)

Country Link
US (1) US20160122420A1 (enExample)
EP (1) EP3004173B1 (enExample)
JP (1) JP2016528176A (enExample)
CN (1) CN105431457A (enExample)
CA (1) CA2914555A1 (enExample)
WO (1) WO2014195713A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402890D0 (en) 2014-02-18 2014-04-02 Iqur Ltd Vaccines based on hepatitis B Core antigens
GB201421692D0 (en) * 2014-12-05 2015-01-21 Iquar Ltd Vaccines based on hepatitis B core antigens
CN107531780B (zh) * 2015-02-03 2021-11-02 国家健康与医学研究院 抗-Rho GTPase的构象单域抗体及其用途
US11078240B2 (en) 2016-11-11 2021-08-03 Fraunhofer Usa Inc. Covalently fused viral coat proteins for the display of target molecules
CN113138276B (zh) * 2020-01-19 2022-09-16 厦门万泰凯瑞生物技术有限公司 用于检测HBcAg的方法及抗体
US12350286B2 (en) * 2020-02-27 2025-07-08 Quadrumix Biotechnology Inc. Polypeptides directed against viral infection and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0737750T3 (da) 1989-03-21 2003-09-01 Vical Inc Ekspression af exogene polynucleotidsekvenser i vertebrater
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
AU671450B2 (en) 1992-03-20 1996-08-29 Baylor College Of Medicine A DNA transporter system and method of use
ES2221920T3 (es) 1992-04-03 2005-01-16 The Regents Of The University Of California Sistema de liberacion de polinucleotidos de autoensamblaje que comprende un peptido cationico anfipatico.
US5651981A (en) 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection
US5527928A (en) 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
CA2405438C (en) * 2000-04-07 2011-07-12 University Of Leeds Innovations Limited Hepatitis b core antigen fusion proteins
GB2410497B (en) 2002-09-27 2006-11-22 Powderject Res Ltd Nucleic acid coated particles
US20120015899A1 (en) * 2008-10-25 2012-01-19 Plant Bioscience, Limited Modified plant virus particles and uses therefor
GB0918679D0 (en) * 2009-10-23 2009-12-09 Iqur Ltd Influenza vaccine
US20130017210A1 (en) * 2010-03-17 2013-01-17 Stc.Unm Display of antibody fragments on virus-like particles of rna bacteriophages

Similar Documents

Publication Publication Date Title
JP2016528176A5 (enExample)
Christensen et al. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory
Plotkin et al. The development of vaccines: how the past led to the future
JP6774149B2 (ja) エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産
Ibanez et al. M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A
JP2011521662A5 (enExample)
JP2016505635A5 (enExample)
JP2018536393A5 (enExample)
JP2012525128A5 (enExample)
JP2017507117A5 (enExample)
JP2009515831A5 (enExample)
JP2011519869A5 (enExample)
JP2015524422A5 (enExample)
Reese et al. A novel lactococcal vaccine expressing a peptide from the M2 antigen of H5N2 highly pathogenic avian influenza A virus prolongs survival of vaccinated chickens
Fang et al. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies
JP2017526689A5 (enExample)
JP2018500878A5 (enExample)
JP2017511140A5 (enExample)
JP2018517419A5 (enExample)
RU2018101722A (ru) Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии
JP2015529677A5 (enExample)
Wang et al. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice
Yang et al. Display of streptococcus iniae α-enolase on the surface of virus-like particles (VLPs) of nervous necrosis virus (NNV) using SpyTag/SpyCatcher
RU2012137304A (ru) Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное
Zhao et al. Protective immunity against infectious spleen and kidney necrosis virus induced by mannose modified subunit vaccine with carbon nanotubes in mandarin fish